ArticleBMC infectious diseases2026
Trichosporon asahii subcutaneous soft tissue infection after trauma surgery in an immunocompetent patient: a case report.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Trichosporon asahii (T. asahii) is a rare non-Candida basidiomycetous yeast. It commonly causes invasive infections in immunocompromised individuals, while severe subcutaneous soft tissue infections in immunocompetent patients are extremely uncommon.Here, we report a 67-year-old immunocompetent female who developed secondary T. asahii infection after debridement and suturing for left lower leg trauma, presenting with local skin necrosis, purulent exudation and undermining abscesses, with normal systemic inflammatory markers. The pathogen was confirmed as T. asahii via Vitek Compact system, MALDI-TOF mass spectrometry and next-generation sequencing (NGS). Antifungal susceptibility testing verified susceptibility to voriconazole. The patient achieved marked improvement after 3 weeks of treatment with surgical debridement, vacuum sealing drainage (VSD) and voriconazole. Local infection was controlled and the wound began to heal, and antifungal drugs were then withdrawn. This case highlights that T. asahii infection should be suspected in refractory post-traumatic soft tissue infections in immunocompetent patients. The discordance between severe local lesions and minimal systemic inflammation serves as a key clinical clue. Early etiological diagnosis, surgical intervention combined with susceptible antifungal agents are critical for improving prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.